425 related articles for article (PubMed ID: 2522347)
41. Both autocrine and paracrine effects of transfected acidic fibroblast growth factor are involved in the estrogen-independent and antiestrogen-resistant growth of MCF-7 breast cancer cells.
Zhang L; Kharbanda S; Hanfelt J; Kern FG
Cancer Res; 1998 Jan; 58(2):352-61. PubMed ID: 9443417
[TBL] [Abstract][Full Text] [Related]
42. Comparison of the effects of a pure steroidal antiestrogen with those of tamoxifen in a model of human breast cancer.
Osborne CK; Coronado-Heinsohn EB; Hilsenbeck SG; McCue BL; Wakeling AE; McClelland RA; Manning DL; Nicholson RI
J Natl Cancer Inst; 1995 May; 87(10):746-50. PubMed ID: 7563152
[TBL] [Abstract][Full Text] [Related]
43. 2-Phenylbenzo[b]furans: relationship between structure, estrogen receptor affinity and cytostatic activity against mammary tumor cells.
Erber S; Ringshandl R; von Angerer E
Anticancer Drug Des; 1991 Nov; 6(5):417-26. PubMed ID: 1764164
[TBL] [Abstract][Full Text] [Related]
44. Dietary genistein negates the inhibitory effect of tamoxifen on growth of estrogen-dependent human breast cancer (MCF-7) cells implanted in athymic mice.
Ju YH; Doerge DR; Allred KF; Allred CD; Helferich WG
Cancer Res; 2002 May; 62(9):2474-7. PubMed ID: 11980635
[TBL] [Abstract][Full Text] [Related]
45. Effect of steroidal and nonsteroidal antiestrogens on the growth of a tamoxifen-stimulated human endometrial carcinoma (EnCa101) in athymic mice.
Gottardis MM; Ricchio ME; Satyaswaroop PG; Jordan VC
Cancer Res; 1990 Jun; 50(11):3189-92. PubMed ID: 2334915
[TBL] [Abstract][Full Text] [Related]
46. Additive and synergistic effects of a novel antiestrogen, toremifene (Fc-1157a), and human interferons on estrogen responsive MCF-7 cells in vitro.
Kangas L; Nieminen AL; Cantell K
Med Biol; 1985; 63(4):187-90. PubMed ID: 2419713
[TBL] [Abstract][Full Text] [Related]
47. Progression of MCF-7 breast cancer cells to antiestrogen-resistant phenotype is accompanied by elevated levels of AP-1 DNA-binding activity.
Dumont JA; Bitonti AJ; Wallace CD; Baumann RJ; Cashman EA; Cross-Doersen DE
Cell Growth Differ; 1996 Mar; 7(3):351-9. PubMed ID: 8838865
[TBL] [Abstract][Full Text] [Related]
48. Hormonal control of growth and progression in tumors of Nb rats and a theory of action.
Noble RL
Cancer Res; 1977 Jan; 37(1):82-94. PubMed ID: 830424
[TBL] [Abstract][Full Text] [Related]
49. Effects of tamoxifen, medroxyprogesterone acetate and estradiol on tumor growth and oncogene expression in MCF-7 breast cancer cell line transplanted into nude mice.
Mizukami Y; Tajiri K; Nonomura A; Noguchi M; Taniya T; Koyasaki N; Nakamura S; Matsubara F
Anticancer Res; 1991; 11(3):1333-8. PubMed ID: 1832273
[TBL] [Abstract][Full Text] [Related]
50. Tissue distribution of transdermal toremifene.
Soe L; Wurz GT; Mäenpää JU; Hubbard GB; Cadman TB; Wiebe VJ; Theon AP; DeGregorio MW
Cancer Chemother Pharmacol; 1997; 39(6):513-20. PubMed ID: 9118463
[TBL] [Abstract][Full Text] [Related]
51. Growth medium for the evaluation of antiestrogenic compounds in MCF-7 cell culture.
Jain PT; Pento JT
Methods Find Exp Clin Pharmacol; 1991 Nov; 13(9):595-8. PubMed ID: 1787766
[TBL] [Abstract][Full Text] [Related]
52. Estrogen suppression of erbB2 expression is associated with increased growth rate of ZR-75-1 human breast cancer cells in vitro and in nude mice.
Wärri AM; Laine AM; Majasuo KE; Alitalo KK; Härkönen PL
Int J Cancer; 1991 Oct; 49(4):616-23. PubMed ID: 1680817
[TBL] [Abstract][Full Text] [Related]
53. [Effect of tamoxifen on estrogen-stimulated growth of MCF-7 tumors in athymic mice: preliminary report].
Iino Y; Izuo M; Jordan VC
Nihon Geka Gakkai Zasshi; 1990 Aug; 91(8):1050. PubMed ID: 2233661
[No Abstract] [Full Text] [Related]
54. Comparison of the effects of EM-652 (SCH57068), tamoxifen, toremifene, droloxifene, idoxifene, GW-5638 and raloxifene on the growth of human ZR-75-1 breast tumors in nude mice.
Gutman M; Couillard S; Roy J; Labrie F; Candas B; Labrie C
Int J Cancer; 2002 May; 99(2):273-8. PubMed ID: 11979444
[TBL] [Abstract][Full Text] [Related]
55. Effects of toremifene and its main metabolites on growth of breast cancer cell lines.
Coradini D; Biffi A; Cappelletti V; Di Fronzo G
Anticancer Res; 1991; 11(6):2191-7. PubMed ID: 1837981
[TBL] [Abstract][Full Text] [Related]
56. A new triphenylethylene derivative, TAT-59; hormone receptors; insulin-like growth factor 1; and growth suppression of hormone-dependent MCF-7 tumors in athymic mice.
Iino Y; Takai Y; Ando T; Ohwada S; Yokoe T; Sugamata N; Takei H; Horiguchi J; Iijima K; Morishita Y
Cancer Chemother Pharmacol; 1994; 34(5):372-6. PubMed ID: 8070003
[TBL] [Abstract][Full Text] [Related]
57. Selective estrogenic effects of a novel triphenylethylene compound, FC1271a, on bone, cholesterol level, and reproductive tissues in intact and ovariectomized rats.
Qu Q; Zheng H; Dahllund J; Laine A; Cockcroft N; Peng Z; Koskinen M; Hemminki K; Kangas L; Väänänen K; Härkönen P
Endocrinology; 2000 Feb; 141(2):809-20. PubMed ID: 10650964
[TBL] [Abstract][Full Text] [Related]
58. Growth properties and tumorigenesis of MCF-7 cells transfected with isogenic mutants of rasH.
Sommers CL; Papageorge A; Wilding G; Gelmann EP
Cancer Res; 1990 Jan; 50(1):67-71. PubMed ID: 2403419
[TBL] [Abstract][Full Text] [Related]
59. Hypophysectomy and injections of high doses of estrogens inhibit the growth of ovary-independent rat mammary carcinomas.
Nomura S; Yoshida H; Kaneko Y
In Vivo; 1990; 4(2):121-5. PubMed ID: 1966585
[TBL] [Abstract][Full Text] [Related]
60. The paracrine stimulation of MCF-7 cells by MDA-MB-231 cells: possible role in antiestrogen failure.
Robinson SP; Jordan VC
Eur J Cancer Clin Oncol; 1989 Mar; 25(3):493-7. PubMed ID: 2703004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
